Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Krestine Rosager Hansen1, Jesper Kjærgaard1, Helene Kvistgaard2

  • 1Afdeling for Børn og Unge, Københavns Universitetshospital - Rigshospitalet.

Ugeskrift for Laeger
|January 18, 2024
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cholesteryl ester storage disease-a rare case of elevated liver enzymes and cholesterol levels with similarities to familial hypercholesterolaemia: a case report.

European heart journal. Case reports·2026
Same author

Early discontinuation of empirical antibiotics versus extended treatment in children with cancer and high-risk febrile neutropenia in Denmark: an open-label, randomised controlled trial.

The Lancet. Child & adolescent health·2026
Same author

Functional Characterization of an IL2RG Variant, a Case Report of X-Linked T- B + NK + SCID.

Immunity, inflammation and disease·2025
Same author

Disability pension and sick leave in people with HIV compared with the background population - a nationwide population-based matched cohort study.

AIDS (London, England)·2025
Same author

Risk of schizophrenia spectrum disorders among people with HIV: a nationwide, population-based, matched cohort study.

AIDS (London, England)·2025
Same author

No changes in weight, body composition or metabolic parameters after the switch to dolutegravir and lamivudine compared to continued treatment with dolutegravir, abacavir and lamivudine for virologically suppressed HIV infection (The AVERTAS trial).

BMC infectious diseases·2025

Treating chronic hepatitis C (HCV) in children with direct-acting antivirals (DAA) offers improved efficacy and safety. Early detection and treatment are recommended to prevent severe liver disease and transmission.

Area of Science:

  • Pediatric Gastroenterology and Hepatology
  • Infectious Diseases
  • Pharmacology

Background:

  • Chronic hepatitis C virus (HCV) infection in children can lead to serious liver complications like fibrosis, cirrhosis, and cancer.
  • Historically, HCV treatment options for children were limited, with lower efficacy and more side effects.
  • Recent advancements include the development and approval of direct-acting antiviral (DAA) medications for pediatric HCV treatment.

Conclusions:

  • Direct-acting antiviral (DAA) therapy represents a significant advancement in the management of chronic hepatitis C (HCV) in children.
  • Active case finding and prompt treatment are essential to mitigate the risk of liver disease progression and onward transmission.
  • Continued research and surveillance are necessary to optimize pediatric HCV care and eradication strategies.

Related Experiment Videos